Tenet Q1 adj EPS $1.42 rev $5.02B; raises FY23 EBITDA outlook to $3.21-3.41B

TENET HEALTHCARE CORP

2023-Q1 EPS reported $1.32 revenue$5,021,000,000

Q1 net income from continuing ops $143M ($1.32 dil EPS); adj diluted EPS $1.42 vs $1.90 YoY.
Consolidated Adj EBITDA $832M incl $3M grants; ex-grants $829M vs $882M prior.
Ambulatory segment revs +22.6% to $905M; Adj EBITDA ex-grants +21.4% to $340M.
Hospital segment Adj EBITDA ex-grants $402M vs $510M; included $27M cyber insurance proceeds.
FY2023 Adj EBITDA outlook raised to $3.21-3.41B; Q2 outlook Adj EBITDA $765-815M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

TENET HEALTHCARE CORP reported the quarter ended March 31, 2023 results: revenue $5,021, net income $143 million, EPS $1.32 per diluted share. Guidance raised.

Period: the quarter ended March 31, 2023
Revenue: $5,021
Net income: $143 million
EPS: $1.32 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

results for first quarter 2023 versus first quarter 2022 are as follows: Three Months Ended March 31, ($ in millions, except per share results) 2023 2022 Net operating revenues $5,021 $4,745 Net income available to Tenet common shareholders from continuing operations $143 $139 Net income available to Tenet common shareholders from continuing operations per

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

TENET HEALTHCARE CORP filing history →

Source: SEC EDGAR

accession 0000070318-23-000015

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.